GlobalAmericasAsiaEuropeMEA
Friday 10 September 2010
Log in Subscribe
Email
Password
Remember me
Magazine Archive
News
Deals
Fundraising
Listed PE
LP Watch
People
Features
Private Equity Manager
Multimedia
Comment
Friday Letter
All topics
Valuation
Accounting
Regulation
Tax
Legal
Compliance / Risk
IR / Communications
Terms & Conditions
GP Management
Human Capital
Online store
Events
Contact us
Home
The PEI Active Portfolio Management Forum

SK Capital eyes healthcare with new hires

The New York-based firm, which spun out of Arsenal Capital in 2007, has hired two Arsenal healthcare specialists, including Aaron Davenport.

SK Capital Partners has hired Aaron Davenport and Jim Marden as managing directors on the firm’s investment team to focus on healthcare investments. Both men previously headed the healthcare investment team at Arsenal Capital, which SK Capital spun out of in 2007.  
 
“Aaron , Jim and I collaborated on several successful investments while at Arsenal,” said SK Capital co-founder and managing director Barry Siadet in a statement. SK Capital co-founder and managing director Jamshid Keynejad said the addition of Davenport and Marden would bolster the firm’s investment effort in “selected segments of health care”.

SK Capital’s investments are typically control buyouts of U.S.-headquartered mid-market companies with enterprise values less than $500 million. The New York-based firm focuses on the specialty materials, chemicals and healthcare sectors. 

James Marden

 
SK Capital currently has two portfolio companies, Aristech Acrylics, a manufacturer of acrylic sheeting, and Ascend Performance Materials, a proprietary technology company central to the production of nylon, plastics and synthetic fibers found in thousands of commercial and industrial products. The combined revenues of the two companies exceed $2 billion.

In April 2009, SK Capital bought the nylon business of Solutia, a developer of specialty chemicals, fibers and fluids, for $50 million. The purchase was made from SK’s second fund, which it began raising in 2009, targeting $400 million with a hard cap of $500 million. The fund had already raised about $100 million in private capital as of April 2009, a source with knowledge of the situation told PEO. It's unclear if the fund has closed. 

SK’s first fund consisted of money from the firm’s principals raised in 2008 for the acquisition of Aristech, which was acquired in April 2008 from Mitsubishi for an undisclosed amount. SK promoted former Goldman Sachs managing director Clark Winter to the position of chief investment officer in December 2008.

 


Bookmark with      
© PEI Media Ltd. All rights reserved. Content on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of PEI Media or in the case of third party content, the owner of that content. You may not alter or remove any trademark, copyright or other notice from copies of the content. You may download material from this site (one machine readable copy and one print copy per page) for your personal, non-commercial use only.